Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer

NCT00448149 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Renal Cell

Interventions

DRUG: RAD001
DRUG: Sorafenib

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]